English
Polski
Español
українська
Milestones in VTE treatment
Prof. Mark Crowther discusses recent milestones in the development of thromboembolism treatment.
2016-05-25
Prof. Mark Crowther discusses recent milestones in the development of thromboembolism treatment.
Prof. Waleed Alhazzani shares his views on stress ulcer prophylaxis in critically ill patients.
Prof. Mark Crowther looks back at 2015 highlights in hematology and thromboembolism.
Prof. Hertzel Gerstein talks about target blood pressure in patients with type 2 diabetes in light of ACCORD and SPRINT trials.
Prof. Waleed Alhazzani discusses recent trials of early goal-directed therapy for septic shock.
Prof. Hertzel Gerstein discusses the effects of empagliflozin on serious health outcomes, including mortality.
Prof. James Douketis talks about managing perioperative cardiovascular risk, bleeding risk, and direct-acting oral anticoagulants.
Prof. James Douketis explains the questions behind the BRIDGE trial and its results (managing warfarin in the periprocedural and perioperative period).
Prof. Gordon Guyatt discusses the recent SPRINT trial and its implications for setting targets in blood pressure treatment.
Prof. Gordon Guyatt discusses the use of aspirin in primary prevention of cardiovascular events.
